Diabetes Clinical Trials in Philadelphia

Showing 161-180 of 303 trials

Improving Outcomes in Underserved Women With GDM

NCT00774124

Our objective is to test an innovative approach to improve outcomes among underserved women with gestational diabetes. We ill utilize a multi-lingual, Interactive Voice Response (IVR) -enabled telephone system to facilitate diabetes control and thereby improve pregnancy outcomes. Our hypothesis is that Telemonitoring will improve maternal glycemia, thereby reducing infant birth weights and leading to improved pregnancy outcomes.

Diabetes MellitusPregnancy

Temple University57 participantsStarted Aug 2007

Tallahassee, Florida, United States • Philadelphia, Pennsylvania, United States

COMPLETEDPHASE3< 1 mile

A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms

NCT02298192

This trial is conducted in Europe, North America and the United States of America. The aim of this trial is to compare two different titration algorithms of insulin degludec/liraglutide.

DiabetesDiabetes Mellitus, Type 2

Novo Nordisk A/S420 participantsStarted Nov 2014

Hamilton, Alabama, United States • Chandler, Arizona, United States • Glendale, Arizona, United States +81 more locations

Improving Outcomes in Underserved Women With GDM

A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms

Diabetes Trials in Other Cities

Study of Antithymocyte Globulin for Treatment of New-onset T1DM

Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes

Study In People With Type 2 Diabetes

A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin

Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes Mellitus

Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes

Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive

GAPP 1 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Diabetes Mellitus

BD FlowSmart™ Subcutaneous Insulin Infusion Set User Preference and Claims Study

TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)

Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 Diabetes

Healthy.io Method Comparison & User Performance Study

The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes

Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes

Thiazolidinedione Intervention With Vitamin D Evaluation

Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease

A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes

A Study To Assess The Safety And Tolerability Of GSK189075 When Given With A Total Daily Dose Of >/ 2000mg of Metformin

Other Conditions in Philadelphia